| Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 331show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall_molecule 937 trials (211 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 937 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 924 trials (209 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 924 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall_molecule 873 trials (258 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 873 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 609 trials (207 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 609 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 503 trials (98 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 503 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 459 trials (105 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 459 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 410 trials (96 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 410 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 383 trials (58 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 383 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 373 trials (77 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 373 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall_molecule 334 trials (79 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 334 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 323 trials (36 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 323 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 258 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 258 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 243 trials (38 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 243 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 235 trials (44 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 235 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 218 trials (117 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 218 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 197 trials (83 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 197 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 185 trials (52 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 185 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 183 trials (67 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 183 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 181 trials (65 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 181 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 164 trials (83 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 164 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 151 trials (81 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 151 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 143 trials (15 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 143 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 133 trials (38 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 133 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 128 trials (47 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 128 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 119 trials (19 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 119 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 111 trials (41 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 111 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 108 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 108 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 97 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 97 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 91 trials (15 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 91 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 87 trials (13 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 87 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 76 trials (56 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 74 trials (14 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall_molecule 74 trials (21 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 71 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 69 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 69 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 66 trials (50 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacarbazinesmall molecule 66 trials (23 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 65 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 59 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belantamab Mafodotinadc 59 trials (38 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elotuzumabmonoclonal antibody 58 trials (18 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall_molecule 58 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Isatuximabmonoclonal antibody 56 trials (43 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 54 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 54 trials (26 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall_molecule 53 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 52 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 52 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 51 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 51 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 46 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teclistamabmonoclonal antibody 46 trials (42 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elranatamabmonoclonal antibody 45 trials (36 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 43 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 43 trials (15 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 43 trials (37 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall_molecule 43 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 42 trials (37 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 40 trials (36 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 39 trials (31 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 37 trials (25 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Procarbazinesmall molecule 37 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 36 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 35 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talquetamabmonoclonal antibody 32 trials (27 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall_molecule 31 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 31 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 30 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 30 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 28 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 28 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 27 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 27 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibritumomab Tiuxetanmonoclonal antibody 27 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal_antibody 26 trials (19 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 25 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 25 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 24 trials (15 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 24 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall_molecule 24 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 23 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 23 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall_molecule 23 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 22 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 21 trials (12 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 21 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 20 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 20 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 20 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 20 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 20 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 19 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 18 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 18 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 18 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 18 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CHOP Regimen 17 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 17 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 16 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 16 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linvoseltamabmonoclonal antibody 16 trials (14 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 16 trials (10 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 15 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 15 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mechlorethaminesmall molecule 14 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 14 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall_molecule 14 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idecabtagene Vicleucelgene therapy 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 11 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nirogacestatsmall molecule 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 10 trials (9 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ciltacabtagene Autoleucelgene therapy 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brexucabtagene Autoleucelgene therapy 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Galiximabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalan Flufenamidesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bimiralisibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic Cell Transplantation 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mocetinostatsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ridaforolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teniposidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brigatinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfa-2bother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pixantronesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lymphoma | 3 | Observed | clinicaltrials | graph → |